Business News Agency February 28th According to a recent research report released by a professional research institute, this year, the country's policies and work arrangements for the pharmaceutical industry are intensively introduced. Under the influence of related policies, the consolidation of China's pharmaceutical industry is imperative. Market mergers and acquisitions will enter an accelerated period.
The data shows that since the fourth quarter of 2010, foreign companies have set off a small round of investment and mergers and acquisitions in China. In addition, foreign companies also have their R&D bases in China, which will inevitably accelerate the integration process of the domestic medical industry.
The analysis pointed out that the total cash of pharmaceutical listed companies in the third quarter of 2010 was 86.857 billion yuan; the desire to become bigger and stronger is very strong for listed companies that display heavy profits.
The data shows that since the fourth quarter of 2010, foreign companies have set off a small round of investment and mergers and acquisitions in China. In addition, foreign companies also have their R&D bases in China, which will inevitably accelerate the integration process of the domestic medical industry.
The analysis pointed out that the total cash of pharmaceutical listed companies in the third quarter of 2010 was 86.857 billion yuan; the desire to become bigger and stronger is very strong for listed companies that display heavy profits.
Antioxidants Vitamins,Antioxidant Vitamins Tablets,Rubber Antioxygen,Antioxidants Free Radicals
SHANDONG BAISHENG BIOTECHNOLOGY COM , https://www.baishengbioproducts.com